Trending stocks

Vadilal Industries reports 13.4% EBITDA decline while 9.6% Revenue growth

01-06-2015 • About Vadilal Industries ($VADILALIND) • By InTwits

Vadilal Industries reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • EBITDA Margin is quite volatile: 8.9% in FY2015, 11.2% in FY2014, 11.6% in FY2013, 19.8% in FY2012, 10.1% in FY2011
  • Vadilal Industries has medium CAPEX intensity: 5 year average CAPEX/Revenue was 10.0%. At the same time it's a lot of higher than industry average of 3.2%.
  • CAPEX is quite volatile: 89.6 in FY2015, 218 in FY2014, 305 in FY2013, 347 in FY2012, 480 in FY2011
  • The company has business model with low profitability: ROIC is at 7.9%
  • It operates with high leverage: Net Debt/EBITDA is 4.0x while industry average is 0.8x
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

Vadilal Industries ($VADILALIND) key annual financial indicators

mln. INR201120122013201420152015/2014
P&L
Revenue2,3882,8463,2373,6734,0269.6%
EBITDA240564374413358-13.4%
Net Income47585023246.0%
Balance Sheet
Cash6691442192.4%
Short Term Debt7656169338148656.3%
Long Term Debt623835756820613-25.3%
Cash flow
Capex48034730521890-58.9%
Ratios
Revenue growth-50.6%19.2%13.7%13.5%9.6%
EBITDA growth23.3%134.7%-33.7%10.5%-13.4%
EBITDA Margin10.1%19.8%11.6%11.2%8.9%-2.4%
Net Income Margin2.0%2.0%1.6%0.6%0.6%-0.0%
CAPEX, % of revenue20.1%12.2%9.4%5.9%2.2%-3.7%
ROIC9.6%20.5%9.2%9.4%7.9%-1.5%
ROE11.5%7.6%4.5%2.0%2.1%0.1%
Net Debt/EBITDA5.8x2.6x4.5x3.9x4.0x0.1x

Revenue and profitability


The company's Revenue increased on 9.6% in FY2015. Revenue growth was financed by EBITDA margin decline. EBITDA Margin decreased on 2.4 pp from 11.2% to 8.9% in FY2015.

Net Income marign showed almost no change in FY2015.

Capital expenditures (CAPEX) and working capital investments


Vadilal Industries's CAPEX/Revenue was 2.2% in FY2015. CAPEX/Revenue decreased on 10.0 pp from 12.2% in FY2012 to 2.2% in FY2015. It's average level of CAPEX/Revenue for the last three years was 5.9%.

Return on investment


The company operates at low ROIC (7.94%) and ROE (2.15%). ROIC decreased slightly on 1.5 pp from 9.4% to 7.9% in FY2015. ROE showed almost no change in FY2015.

Leverage (Debt)


Company's Net Debt / EBITDA is 4.0x and Debt / EBITDA is 4.1x. Net Debt / EBITDA increased on 0.1x from 3.9x to 4.0x in FY2015. Debt decreased on 9.6% in FY2015 while cash surged on 192% in FY2015.

Valuation


The company's trades at EV/EBITDA 13.8x and P/E 144.5x while industy averages are 10.5x and 26.1x. Vadilal Industries's EV/(EBITDA-CAPEX) is 18.5x with the industry average at 4.7x.

Appendix 1: Peers in Packaged Foods


Below you can find Vadilal Industries benchmarking vs. other companies in Packaged Foods industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Simran Farms ($SIMRAN)38.4%23.8%27.5%23.4%
Heritage Foods ($HERITGFOOD)27.1%15.0%7.5%20.4%
Rcl Foods ($RCLFOODS)-56.8%-34.2%18.2%17.8%
Umang Dairies ($UMANGDAIR)46.8%15.7%24.5%16.1%
Britannia Industries ($BRITANNIA)19.0%12.4%11.3%13.8%
 
Median (13 companies)-28.9%14.7%15.0%16.0%9.6%
Vadilal Industries ($VADILALIND)19.2%13.7%13.5%9.6%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Glaxosmithkline Consumer Healthcare ($GSKCONS)18.8%18.6%17.8%22.5%17.2%
Sampre Nutritions ($SAMPRE)16.8%
Krbl ($KRBL)14.7%14.1%14.2%15.1%15.4%
Adf Foods ($ADFFOODS)16.2%13.5%11.2%8.6%14.5%
Britannia Industries ($BRITANNIA)5.2%5.7%6.9%9.2%11.1%
 
Median (14 companies)5.8%7.2%7.1%7.1%6.6%
Vadilal Industries ($VADILALIND)10.1%19.8%11.6%11.2%8.9%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Venky'S (India) ($VENKYS)6.4%8.9%6.6%10.4%7.7%
Krbl ($KRBL)5.8%4.1%4.0%6.1%7.3%
Umang Dairies ($UMANGDAIR)1.2%2.0%4.4%2.7%3.2%
Glaxosmithkline Consumer Healthcare ($GSKCONS)3.6%2.7%4.3%2.5%
Heritage Foods ($HERITGFOOD)2.8%2.1%1.9%3.7%2.5%
 
Median (7 companies)3.1%3.7%3.9%3.7%2.5%
Vadilal Industries ($VADILALIND)20.1%12.2%9.4%5.9%2.2%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Kse ($KSE)14.7%27.7%14.1%36.9%69.0%
Britannia Industries ($BRITANNIA)17.8%24.6%33.7%54.0%59.4%
Glaxosmithkline Consumer Healthcare ($GSKCONS)45.0%44.6%36.2%
Umang Dairies ($UMANGDAIR)54.8%93.5%55.6%22.3%28.4%
Krbl ($KRBL)14.4%11.7%14.5%18.3%17.0%
 
Median (16 companies)13.1%12.1%14.1%22.3%28.4%
Vadilal Industries ($VADILALIND)9.6%20.5%9.2%9.4%7.9%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Venky'S (India) ($VENKYS)0.9x2.6x2.8x6.7x3.9x
Krbl ($KRBL)3.7x4.1x2.9x3.0x2.7x
Heritage Foods ($HERITGFOOD)3.5x2.2x0.9x1.0x1.4x
Umang Dairies ($UMANGDAIR)1.8x0.6x0.5x1.7x1.1x
Sampre Nutritions ($SAMPRE)2.9x0.0x0.0x0.0x
 
Median (13 companies)2.2x1.7x0.8x0.7x0.0x
Vadilal Industries ($VADILALIND)5.8x2.6x4.5x3.9x4.0x